Professional Documents
Culture Documents
9-1981
Douglas R. Swinehart
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons
Recommended Citation
Venkatasubramaniam, K. V. and Swinehart, Douglas R. (1981) "Behcet's Syndrome: Case Report and
Literature Review," Henry Ford Hospital Medical Journal : Vol. 29 : No. 3 , 153-159.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol29/iss3/7
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been
accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System
Scholarly Commons.
Henry Ford Hosp Med
Vol 29, No 3, 1981
Behcet's syndrome is a disease commonly found in japan presented with symptoms four months after he developed
and in countries around the Mediterranean Sea. In the U.S., arthritis and who had been initially diagnosed as having
it is relatively uncommon. This report describes a 24-year- incomplete Reiter's syndrome. A literature review is
old Lebanese-American man with Behcet's syndrome who Included.
In 1937, a Turkish dermatologist, Hulusi Behcet, described tients, for a prevalence rate of 0.67:1,000 persons (6,7).
a triple syndrome consisting of recurrent, painful oral and More patients were found in the colder, northern parts of
genital ulcers and recurrent ulcers of the eye. His original Japan (6,7). This prevalence rate is about ten times greater
description was based upon an examination of three pa- than that of northern England, where a survey done at
tients (1). The syndrome is now recognized as a multi- Yorkshire found 32 patients in a population of five million
systemic disorder with mucocutaneous, ocular, intestinal, (8). In the U.S., the prevalence rate for Olmstead County,
articular, vascular, urogenital, and neurological involve- Minnesota was 1:300,000 persons (9). Current estimates in
ment (2,3), and it is classified with other mucocutaneous- Japan place the number of patients wfth Behcet's syndrome
ocular syndromes, e.g., erythema multiforme and Reiter's at 11,000 (9). Interestingly, while the syndrome has been
syndrome (4). The etiology remains unknown. No specific found in Hawaii, none of the diagnosed patients were
diagnostic or therapeutic aid is known. The disease is Japanese or Japanese-Americans, despite the frequency of
common in Japan and in the countries surrounding the the disease in Japan and the large Japanese population in
Mediterranean Sea, such as Turkey, Italy, Greece, Israel, Hawaii (10,11).
Lebanon, and other Arab lands. A few patients with this
syndrome have been diagnosed recently in England and
Germany. However, Behcet's syndrome is still an uncom- Historical Background
mon disease in the U.S. (5). This paper includes a report on
The earliest description of Behcet's syndrome as an acute
a Lebanese-American patient with Behcet's syndrome and
endemic disease can be found in the writings of Hippocr-
a complete literature review.
ates (12). Shigeta (1924), Adamantiadis (1931), and White-
well (1934) described cases similar to Behcet's syndrome
which preceded Behcet's classic paper in 1937 (1,13-15),
Epidemiology from which the presently accepted name derives. Some
In Japan, the number of patients with Behcet's syndrome have used the terms complete, abortive, partial, or in-
has increased dramatically since World War II. In 1972-73, complete to describe the clinical pattems of Behcet's syn-
a nationwide survey yielded an estimated 7000-8500 pa- drome (9), and Lehner has suggested dividing it into two
major categories, the mucocutaneous or benign type and
the neuro-ocular type, which may have more serious con-
sequences (16).
Submitted for publication: March 31, 1981
Accepted for publication: April 22, 1981
153
Venkatasubramaniam and Swinehart
Case Report
A 24-year-old native American-born Lebanese man experi-
enced recurrent painful oral ulcerations for two years.
About four months before his first visit to Henry Ford
Hospital, he noted left knee pain with swelling and subse-
quently developed pain in the right knee, ankles, feet,
elbows, and low back. An incorrect diagnosis of Reiter's
syndrome was made. Although the mucocutaneous lesions
were p a i n f u l , the patient improved on 100 mg Indo-
methacin daily. He was referred to the Rheumatology
Clinic of Henry Ford Hospital in August 1978 because he
had arthralgia and painful skin ulcerations on the shaft of
the penis and scrotum that had been unresponsive to Fig. 1
neosporin ointment, parenteral penicillin, and smallpox Ulcers on the palate suggest Behcet's syndrome.
154
Behcet's Syndrome
1
'mi^myy>
Fig. 3
Skin ulcerations in the peno-scrotal region. Penile skin biopsy showing an inflammatory cellular infiltration of
mononuclear cells located between the collagen bundles and in close
apposition to the blood vessels (H & E 150 X).
Because we suspected Behcet's syndrome, the patient was Metereologic factors have also been claimed as a cause,
hospitalized for further tests. A biopsy from an ulceration of based chiefly on evidence suggesting its greater prevalence
the scrotum revealed that the central portion of the epider- in colder climates and the greater frequency of attacks in
mis was completely eroded and the margins were acantho- Japan during the windy season. Hereditary factors are also
tic. A dense inflammatory infiltrate throughout the dermis implicated. The association between the HLA-B5 antigen
was composed of leukocytes, lymphocytes, plasma cells, and Behcet's syndrome is particularly strong in Japan and
and histiocytes (Fig. 3). Numerous scattered dilated vessels Turkey, the two countries of greatest prevalence. HLA-A2
were seen in the upper dermis. Some vessels in the mid- and HLA-B27 but not B5 was increased in a series from
dermis showed endothelial cell proliferation and an invas- Yorkshire (U.K.), whereas HLA-B27 was not present in a
ion by mononuclear cells. Many vessels were completely recent American study of Behcet's syndrome (5,8,9,18-21).
occluded. These changes were consistent with the ulcers of
Behcet's syndrome. Domeboro compresses were applied One theory is that Behcet's syndrome is an autoimmune
to the open lesions along with Lidex in orabase ointment disorder, since a patient's autoreactive antibody against
four times a day. Indocin (100 mg daily) was continued. The oral mucous membranes has been detected in serum. This
ulcers completely healed in six days. belief has been supported by recent immunofluorescence
studies demonstrating the deposition of IgM, IgG, and beta
IA globulin in the vessel walls of patients with Behcet's
syndrome. The elevated serum complement levels (Cl, C4,
Etiopathogenesis C2 and C3), raised serum IgG, IgM and IgD, proportionate
The etiopathogenesis of Behcet's syndrome is complex and increase of T lymphocytes and suppression of B lympho-
intriguing. The cause is still obscure, but a sequence of cytes in patients with Behcet's syndrome all lend further
immunologic events has been implicated, perhaps precipi- credibility to the immunologic theory. The report of a
tated by genetic, viral, toxic, and allergic factors. macrophage migration inhibitory factor in the anterior
155
Venkatasubramaniam and Swinehart
chamber of the eye in Behcet's syndrome suggests that cell- subcutaneous venules of the extermities. Less commonly,
mediated immunity might play a significant role (9). migrating obi iterative thrombophlebitis has been known to
occur (23).
The immunologic and immunochemical findings in neu-
rological forms of Behcet's syndrome are important. De- Acneiform skin eruptions resembling acne vulgaris appear
myelinating antibodies, similar to those found in multiple frequently on the face, neck, breast, and back. Uncharac-
sclerosis, are detectable in more than 70% of patients with teristically, some lesions can become pustular, but pruritis
Behcet's syndrome and neurologic involvemenL While the is rare (23).
antibodies in multiple sclerosis cause inhibition and de-
struction ofthe myelin, those in Behcet's syndrome do not Abnormal hyper-irritability o f t h e skin against nonspecific
appear to inhibit myelinization. Furthermore, an anti- stimulation is found in 60-70% of patients who have
myelin serum factor (AMSE) has been reported recently in Behcet's syndrome; however, it is not specific for the
the serum and spinal fluid of patients with neuro-Behcet's disorder (10,24,25). In areas where the syndrome is preva-
syndrome during the acute and active phase. A less specific lent, a test that uses an aseptic needle to prick the skin can
factor known as the cerebroside-binding serum factor be extremely helpful in diagnosis. The patient will develop
(CBSF) has also been detected. The elevation of CSF-lgA, a tuberculin-like reaction with erythema and swelling at
alpha-ll macroglobulin, and C3 in patients with neuro- the injection site 24-48 hours later; aseptic pustules will
Behcet's syndrome is useful in assessing its severity. These develop later. The above reaction can be induced by
findings seem to support the concept that an immunologic injection of physiologic saline, the patient's saliva, or the
mechanism might play a significant role in the develop- aseptic extract of a genital ulcer. Although the mechanism
ment of the vascular and neurologic manifestations of ofthis phenomenon is not known, it is thought to be related
Behcet's syndrome (7). to increased chemotaxis.
156
Behcet's Syndrome
redness, and swelling. The knee is the most frequently recognized in Japan. It is usually associated with a poor
involved joint, while the ankle, elbow and wrist are less prognosis. Meningeal disease could mimic the features of
frequently affected. The arthritis is seldom destructive. In microbial meningitis. Vascular occlusions could involve
contrast to Reiter's syndrome, the sacroiliac joint is seldom the cerebral or vertebrobasilar circulation, while par-
involved in Behcet's syndrome. Only 0.5-1% of the Jap- enchymatous involvement leading to brain stem, cerebel-
anese patients showed sacroiliac joint involvement. The lar, and spinal long tract damage have also been well
rheumatoid factor is negative in almost all cases. Rare cases described. Psychological changes, characterized by am-
of erosive arthritis and osteonecrosis of the femur have nesia, dementia and personality disturbances, are present
been documented (23,27-30). in at least 50% of cases (39-42).
157
Venkatasubramaniam and Swinehart
most instances, nervous system and vascular compl ications episodic nor destructive. In the light of a high index of
occur later. In most patients frequent attacks occur early in suspicion clinically, these criteria would justify the diag-
the disease followed by a slowing of activity. Eye symptoms nosis of incomplete Behcet's syndrome, which was consist-
tend to become chronic and eventually lead to loss of ent with the biopsy findings. His positive HLA-B27 antigen
visual acuity or to blindness. is interesting, although a clear relationship between this
factor and Behcet's syndrome remains speculative. Our
Men appear to be affected more often than women (ratio
patient may eventually develop ocular or other manifesta-
1.2 to 2). However, a female preponderance has been
tions characteristic ofthis syndrome. As yet, the patient has
noted in a series reported from the U.S. and the U.K. In
had no serious problems but eventually he might require
general, the younger the patient, the poorer the prognosis.
the therapeutic agents mentioned. His prognosis therefore
Young men usually have the worst prognosis (8,42,44). The
remains guarded.
mucocutaneous lesions without ocular involvement are
relatively frequent in women over 45; this has been termed
the incomplete type of Behcet's syndrome.
Acknowledgments
Prognostic predictors of Behcet's syndrome are not well We wish to thank Dr. Gilbert B. Bluhm and Dr. Clarence
delineated. In general, progression of neurologic disease Livingood for their encouragement and permission to pub-
carries a poor prognosis. Death generally results from lish this case.
lesions of the central nervous system or vascular system
and from intestinal perforation (9).
Management
The treatment of Behcet's syndrome is controversial and
difficult. Some aspects of therapy continue to be empirical
and palliative. Transfer factor has been used in some
studies and has had moderate-to-great effectiveness in
controlling some recalcitrant lesions and in reducing the
number of new lesions and new attacks. More recently,
immunosuppressive therapy has been recommended,
while immunostimulant drugs (e.g., Levamisole) have also
been used. Colchicine has been used in some cases, chiefly
because of its antichemotactic activity. In the past,
fibrinolytic drugs have also been used, chiefly to combat
the fibrinolytic deficiency. Corticosteroids have largely
been used as a palliative mode of therapy (9).
Discussion
In the U.S., Behcet's syndrome is still considered rather
uncommon (5,28), although Duffy, et al (44) believe that
the disease usually passes unrecognized and is not that
rare. They described clinical and immunologic findings in
10 patients with Behcet's syndrome. Other cases reported
in the U.S. include that of a 49-year-old woman with
uveitis, recurrent orogenital lesions, polyarthritis, and skin
lesions (30); a patient with recurrent pneumonia associated
with Behcet's syndrome that occurred over 13 years; a
patient with thrombophlebitis, skin lesions, diffuse pul-
monary infiltrate, and severe hemoptysis (45); and a patient
with Behcet's syndrome and neurologic involvement (22).
158
Behcet's Syndrome
References
1. Behcet H. Uber rezidivierende aphthose, durch ein Virus Verursachte 23. Bietti GB, Bruna R. An ophthalmic report on Behcet's disease. In: Int
Geschwure am Mund, am Auge und an den Genitalien. Dermatol Symp on Behcet's disease, Rome. Basel: S. Karger, 1966:77.
Wochenschr 1937;105:1152.
24. Matsumara N, Misushima Y. Leukocyte movement and colchincine
2. Oshima Y, Shimizu T Yokohari R, et al. Clinical studies on Behcet's treatment in Behcet's disease. Lancet 1975;2:813.
syndrome. Ann Rheum Dis 1963:22:36.
25. Mizushima Y, Matsumua N, Mori M, et al. Colchicine in Behcet's
3. Robinson H M Jr, M c C r u m b FR Jr. C o m p a r a t i v e analysis of the disease. Lancet 1977;2:1037.
mucocutaneous-ocular syndromes: Report of 11 cases and review of
literature. Arch Dermatol Syphilol 1950;61:539. 26. Shikano S, Araki Y. Ophthalmology of Behcet's disease. Treatment
and progress. Jpn ] Clin Med 1968;26:31.
4. Hagiwara A. Behcet's syndrome. Transactions of XV Ceneral Assem-
bly of Japanese Med Congress 1959:267. 27. Behcet H. Some observations on the clinical picture of the so-called
triple symptom complex. Dermatologica 1940;81:73.
5. O'Duffy JD. Summary of international symposium of Behcet's dis-
ease. J Rheumatol 1978;5:229. 28. Strachan RW, Wigzell FW. Polyarthritis in Behcet's multiple symptom
complex. Ann Rheum Dis 1963:22:26.
6. Yamamoto S, Toyokawa H, Matsubara J, et al. Nationwide survey of
Behcet's disease in Japan. Jpn J Ophthalmol 1974;18:282. 29. Mason RM, Barnes CG. Behcet's syndrome with arthritis. Ann Rheum
Dis 1969;28:95.
7. Masuda K, Inaba G, Mizashima Y, et al. A nationwide survey of
Behcet's disease in Japan. Jpn J Ophthalmol 1975:19:278. 30. Zizic T M , Stevens MB. The arthropathy of Behcet's disease. Johns
Hopkins Med J 1975;136:243.
8. Chamberlain MA. Behcet's syndrome in 32 patients in Yorkshire. Ann
Rheum Dis 1977;36:491. 31. B0e J, Dalgaard JB, Scott D. Mucocutaneous-ocular syndrome with
intestinal involvement. Am J Med 1958;25:857.
9. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behcet disease (Behcet
syndrome). Semin Arthritis Rheum 1979;8:250. 32. Shimizu T, Saitoh Y. Intestinal changes in Behcet's syndrome. Jpn J
Gastroenterol 1968:65:1117.
10. Hirohata T, Kuratsune M, Nomura A, et al. Prevalence of Behcet's
syndrome in Hawaii. Hawaii M e d J 1975;34:244. 33. Shimizu T. Vascular lesions of Behcet's disease. Cardioangiology
1977;1:124.
11. Shimuzu T, Inaba G. Epidemiological studies on Behcet's disease in
Japan. J Jpn Rheum Assoc 1976;16:224. 34. Halm S, Barzilai D, Hazani E. Involvement of veins in Behcet's
syndrome. Br J Dermatol 1971;84:238.
12. Feigenbaum A. Description of Behcet's syndrome in the Hippocratic
third book of endemic diseases. B r j Ophthalmol 1956;40:355. 35. Kansu E, Ozer FL, Akalin E, et al. Behcet's syndrome with obstruction
of venae cavae. Q J Med 1972;41:151.
13. Shigeta T. Recurrent iritis with hypopyon and its pathological findings.
Acta Soc Ophthalmol Jpn 1924:28:516. 36. Rosenthal T, Halkin H, Shani M, et al. Occlusion o f t h e great veins in
the Behcet syndrome. Angiology 1972:23:600.
14. Adamantiadis B. Sur un cas d'iritis a hypopyon recidivante. Ann
Oculist 1931:168:271. 37. Hashimoto T, Matsumoto A, Sh imizu T. Behcet's disease. Medicine
1976:13:334.
15. Whitwell GPB. Recurrent buccal and vulval ulcers w i t h associated
embolic phenomena in skin and eye. B r j Dermatol 1934;46;414. 38. Urayama A. Etiology of iridocyclitis. Clin Ophthalmol 1957;11:837.
16. Lehner T. Progress report: Oral ulceration and Behcet's syndrome. 39. Shimizu T. Epidemiological and clinicopathological studies on neuro-
Gut 1977;18:491, Behcet's syndrome. Adv Neurol Sci 1972;16;167.
17. Behcet's Disease Research Committee of Japan: Behcet's disease; 40. Epstein RS, Cummings NA, Sherwood EB, et al. Psychiatric aspects of
guide to diagnosis of Behcet's disease. Jpn J Ophthalmol 1974;18:291. Behcet's syndrome. J Psychosom Res 1970;14:161.
18. Ohno S, Aoki, Sugiura S, et al. HL-A5 and Behcet's disease. Lancet 41. Pallis CA, Fudge BJ. Neurological complications of Behcet's syn-
1973:2:1383. drome. Arch Neurol Psychiatr 1956;75:1.
19. Ohno S, Nakayama E, Suguira S, et al. Specific histocompatibility 42. O'Duffy JD, Goldstein NP Neurologic involvement in seven patients
antigens associated w i t h Behcet's disease. A m J O p h t h a l m o l with Behcet's disease. Am J Med 1976;61:170.
1975:80:636.
43. Cherian S, Cummings NA. Evaluation of the platelet rosette phe-
20. Yazici H, Akokan C, Muftuoglu A. The high prevalence of HLA-B5 in nomenon (PRP) in Behcet's syndrome. XIV International Congress of
Behcet's disease. XIV International Congress of Rheumatology, 1977 Rheumatology, 1977 (Abst).
(Abst).
44. O'Duffy JD, Carney JA, Deodhar A. Behcet's disease: Report of ten
21. O'Duffy JD, Taswell HF, Elverback LR. HL-A antigens in Behcet's cases, three with new manifestations. Ann Intern Med 1971;75:561.
disease. J Rheumatol 1976;3:1.
45. Cadman EC, Lundberg WB, Mitchell MS. Pulmonary manifestations
22. Calderon R. Behcet's disease with neurological involvement. Henry in Behcet's syndrome. Arch Intern Med 1976;136:944.
Ford Hosp Med Bull 1964;12:205-09.
159